(CLNN) – Litigation
-
Clene (CLNN) Receives Two Patent Notice of Allowances in the U.S. for Its Platform Nanocrystal Therapeutic Technology
-
Clene Nanomedicine (CLNN) Receives Patent Notice of Allowance in the United States for using Gold Nanocrystals for the Treatment of Multiple Sclerosis
Back to CLNN Stock Lookup